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INTRODUCTION
The word sepsis is derived from the Greek 
term for rotten or “to make putrid”. Sepsis, defined 
as the systemic host response to microorganisms in 
previously sterile tissues, is a syndrome related to 
severe infections and is characterized by end-organ 
dysfunction away from the primary site of infection. 
To meet the definition of sepsis, patients need to 
satisfy at least two of the Systemic Inflammatory 
Response Syndrome (SIRS) criteria in association 
with having a suspected or confirmed infection. The 
severity and mortality increase when this condition 
is complicated by predefined organ dysfunction 
(severe sepsis) and cardiovascular collapse (septic 
shock). The normal host response to infection is 
complex, aiming to both identify and control 
pathogen invasion and start immediate tissue repair. 
Both the cellular and humoral immune systems are 
activated, giving rise to anti-inflammatory and 
proinflammatory responses. Exacerbating these 
mechanisms can cause a chain of events that leads to 
sepsis, promoting massive liberation of mediators 
1and the progression of multiple organ dysfunction .
Sepsis remains a critical problem with 
significant morbidity and mortality even in the 
modern era of critical care management. Despite 
intense efforts, sepsis remains a serious clinical 
problem and still associated with a high mortality 
rate. Septic shock and sequential multiple organ 
failure/dysfunction syndrome (MOF/MODS) 
correlate with poor outcome, and septic shock is the 
most common cause of death in intensive care units. 
A recent review by Angus et al estimated the 1995 
incidence of sepsis in the United States to be 751,000 
cases, resulting in 215,000 deaths. The average cost 
per case of sepsis was $22,100 with total costs of 
$16.7 billion nationally. A more recent analysis of 
hospital records indicates that the total number of 
patients who are dying is actually increasing. This 
study also confirmed the work of Angus et al that the 
incidence of sepsis is increasing and projected to 
continue to grow as the population ages. These 
studies concluded that “severe sepsis is a common, 
expensive, and frequently fatal condition, with as 
many deaths annually as those from acute 
2,3myocardial infarction .
The immunological cascade resulting in the 
sepsis response can be initiated by tissue injury, 
ischemia reperfusion injury, gram-positive 
organisms, and fungi as well as gram-negative 
organisms and their constituent endotoxin. The 
sepsis response may begin with an infectious nidus, 
which may either invade the bloodstream, leading to 
dissemination and positive blood cultures, or 
proliferate locally and release various microbial 
3products into the bloodstream .
Multiple derangements exist in sepsis 
involving several different organs and systems, 
although controversies exist over their individual 
contribution to the disease process. Septic patients 
have substantial, life-threatening alterations in their 
coagulation system. Previously, it was believed that 
sepsis merely represented an exaggerated, 
hyperinflammatory response with patients dying 
from inflammation-induced organ injury. More 
recent data indicate that substantial heterogeneity 
exists in septic patients' inflammatory response, 
with some appearing immuno-stimulated, whereas 
others appear suppressed. Cellular changes continue 
the theme of heterogeneity. Some cells work too well 
such as neutrophils that remain activated for an 
extended time. Other cellular changes become 
accelerated in a detrimental fashion including 
2lymphocyte apoptosis . 
The role that apoptosis plays in sepsis 
syndromes and in the development of CARS and 
MODS has not been adequately explored, but there 
is rapidly developing evidence to suggest that 
increased apoptotic processes may play a 
determining role in the outcome to sepsis 
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syndromes. In particular, increased apoptosis, 
particularly in lymphoid tissues and potentially in 
some parenchymal tissues from solid organs, may 
3contribute to the sepsis-associated MODS
APOPTOSIS: Physiological cell death
All tissues must be able to tightly control 
cell numbers and tissue size and to protect 
themselves from rogue cells that threaten 
4homeostasis . Cells can die in two ways: by 
damaging their cell membrane and then undergoing 
necrosis or by shrinking and blebbing the intact cell 
membrane, which leads to apoptosis. Physical or 
chemical injury, such as the deprivation of oxygen 
that occurs in the heart muscle during myocardial 
infarction or in sepsis when the microvasculature is 
disrupted by fibrin deposition and intravascular 
coagulopathies, often leads to cell disintegration or 
necrosis. The necrotic tissue is phagocytosed and 
degraded by phagocytic cells, often leading to 
3inflammation .
An alternative form of cell death is known 
as programmed cell death or apoptosis. Apoptosis is 
a normal cellular process that is crucial for tissue 
remodeling and/or development. For example, most 
thymocytes undergo an apoptotic cell death when 
they fail positive selection or are negatively selected 
as a result of recognizing self-antigens. During 
apoptosis, cells undergo a non-necrotic cellular 
suicide that, in contrast to necrosis, generally does 
3not produce inflammation and injury in the tissue .
The term apoptosis, from Greek origins 
(apo5for, ptosis5falling), was chosen to describe the 
cellular process of programmed cell death. 
Apoptosis is a tightly regulated intracellular 
program in which cells destined to die activate 
enzymes that degrade the cell's DNA and nuclear 
and cytoplasmic proteins. Programmed cell death 
eliminates unwanted cells or potentially reactive cell 
lines either before or after maturation. This process 
is vital to fetal and embryonic development and to 
4tissue remodeling . Cell populations that normally 
have a high rate of proliferation, such as the 
intestinal epithelium, depend upon apoptosis to 
maintain the necessary number of cells. The number 
of activated immune cells must be controlled to 
contain the inflammatory response. Hormone-
dependent apoptosis occurs during estrus and causes 
4 prostatic atrophy after castration .
Apoptosis must be distinguished from 
necrosis, which is also a form of cellular death. In 
contrast to apoptosis, necrosis is not a genetically 
programmed function, it affects groups of 
neighboring cells, and produces an inflammatory 
response. The death of a cell by necrosis leads to the 
release of alarm signal molecules that stimulate 1 or 
more  pa t t e rn - recogn i t ion  recep to r s  on  
macrophages, dendritic cells, and natural killer cells. 
The presence of necrotic cells in a tissue is 
frequently interpreted by the immune system as 
dangerous and therefore acts as a signal to initiate an 
immune response. Unlike apoptosis, with necrosis 
there is cellular swelling with loss of cell membrane 
integrity, organelle swelling, and lysosomal leakage. 
The degradation of DNA is random and lysed cells 
are ingested by macrophages. Whether a cell 
survives or dies by apoptosis is determined by the 
balance between pro-apoptotic (stress ordeath) 
signals and anti-apoptotic (mitogenic or survival) 
4signals within and around the cell .
Apoptosis can be genetically encoded or can 
occur in response to cellular or external stimuli. 
There are 3 features that characterize apoptosis: 
protein cleavage or hydrolysis, breakdown of 
nuclear DNA, and recognition of the apoptotic cell 
4by phagocytic cells .
MECHANISMS OF APOPTOSIS
Initially, apoptosis was considered to be a 
mechanism by which selected cell populations could 
be actively eliminated from specific tissues during 
morphogenesis and tissue remodeling; however, it is 
also thought to have a role in the resolution of the 
5immune response . 
Apoptotic cell death occurs primarily 
through three different pathways: the extrinsic death 
receptor (type I cells), the intrinsic (mitochondrial) 
pathway (type II cells), and the endoplasmic 
5reticulum (ER) or stress-induced pathway .
The extrinsic pathway (see Figure 1) begins 
with pro-apoptotic receptors on the cell's surface 
activated by a pro-apoptotic molecule or ligands 
specific for that receptor. These cell DRs belong to 
the tumor necrosis factor (TNF) receptor 
superfamily, with the Fas receptor and TNFR1 as the 
most intensely studied members. Fas is present on a 
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variety of cell types including activated B cells and T 
cells. Ligands that activate pro-apoptotic receptors 
include the Fas ligand (FasL) and TNF-a37–42 
(Table 1). FasL is expressed by a variety of cell 
types, including activated T cells and natural killer 
cells. TNF-a is produced predominantly by activated 
monocyte/macrophages and lymphocytes. The 
intracellular portion of the DR is known as the death 
domain (DD). Once 3 or more DR-ligand complexes 
bunch, their DDs are brought into close proximity 
and a binding site for an adaptor protein is formed. 
The adaptor protein is specific for that receptor (eg, 
Fas-associated DD [FADD] or TNF receptor-
associated DD [TRADD]). This complex of ligand-
receptor-adaptor protein is called the death-inducing 
signaling complex (DISC), leading to the 
recruitment and assembly of initiator caspases 8 and 
10. These caspases can now undergo self-processing 
and release active caspase enzyme molecules into 
the cytosol. Here, they activate the effector caspases 
3, 6, and 7. Figure 1 illustrates the sequence of events 
4that trigger the extrinsic pathway .
Fig. 1. The extrinsic or death receptor (DR) pathway.
Pro-apoptotic ligands, death signals, and Fas bind to Fas or TNFRs. The intracellular portion of the DR is 
known as the death domain (DD). Bunching of the receptor-ligand complexes groups their DDs and a binding 
site for an adaptor protein is formed. This ligand-receptor-adaptor protein complex is called the death-inducing 
signaling complex (DISC). It recruits and assembles initiator caspase-8 that releases active caspase enzyme 
molecules into the cytosol. Here, they activate the effector caspases-3 and -7, resulting in nuclear protein 
cleavage and the initiation of apoptosis. FasL, Fas ligand; TNFR tumor necrosis factor receptor; FADD, Fas-
associated death domain; TRADD, TNF-associated death domain; c-FLIP, FLICE-like inhibitory protein; 
DISC, death-inducing signaling complex. Source: O'Brien, M.A., et al. Apoptosis: A review of pro-apoptotic 
and anti-apoptotic pathways and dysregulation in disease. Journal of Veterinary Emergency and Critical Care 
18(6). 2008; 572–585.
Intrinsic mitochondrial pathway: The 
intrinsic mitochondrial pathway (see Figure 2) 
is initiated from within the cell in response to 
cellular stresses such as DNA damage, radical 
oxygen species, radiation, hormone or growth-
factor deprivation, chemotherapeutic agents, 
cytokines, and glucocorticoids. Initiation of this 
pathway eventually results in the release of pro-
apoptotic proteins from the mitochondria that 
will activate caspase enzymes and trigger 
apoptosis. The success of the pathway in 
inducing apoptosis depends on the balance of 
activity between pro-apoptotic and anti-
apoptotic members of the B-cell lymphoma-2 
4(Bcl-2) superfamily of proteins .
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apoptosis activating factor-1 (Apaf-1). Cytochrome 
c and Apaf-1 combine with procaspase-9 for 
activation of this caspase (Figure 2). The binding of 
these 3 substances forms an apoptosome, which 
4then activates procaspase-34 .
The third and least understood pathway is 
referred to as the endoplasmic reticulum or ER 
pathway. It involves the activation of caspase 12 by 
+Ca2  and oxidant stress and is said to be able to 
function independently of the mitochondria. 
Cellular stresses such as hypoxia, glucose 
starvation, disturbances in calcium homeostasis, 
and exposure to free radicals injure the ER, resulting 
in the unfolding of proteins and reduction in protein 
4,5synthesis . 
In normal cells, an adaptor protein, TNF 
receptor associated factor 2 (TRAF2), is bound to 
procaspase-12, rendering it inactive. Stress of the 
ER leads to the dissociation of TRAF2, activation of 
caspase-12. Once activated, caspase-12 cleaves 
procaspase-9, which then cleaves procaspase-3. 
This mechanism is independent of the mitochondria 
although there is evidence that caspase 12 can cause 
the release of cytochrome c from the mitochondria 
4and thus stimulate the intrinsic pathway .
SYSTEMIC INFLAMMATORY RESPONSE 
SYNDROME (SIRS) AND MULTIPLE 
ORGAN DYSFUNCTION SYNDROME 
(MODS)
The theory that apoptosis contributes to the 
multiple organ dysfunction of sepsis was 
formulated originally by Bone in 1996. The 
argument put forth postulated that certain 
immunomodu la to ry  f ac to r s  p re sen t  i n  
overwhelming amounts in SIRS could contribute to 
a generalized systemic increase in cellular 
apoptosis, thereby accounting for the organ failure 
6of MODS . Bone proposed that the anergic or 
hypoimmune aspect of sepsis, when apoptosis 
becomes most critical, must also be addressed, 
Apoptotic loss of B cells, T cells, and dendritic cells 
in sepsis decreases antibody  reduction, 
macrophage activation, and antigen presentation, 
4  respectively . As SIRS is essentially an imbalance 
between pro- and anti-inflammatory immune 
activity, it follows that the induction (or even 
inhibition) of apoptosis occurring in SIRS is 
inappropriate and ultimately more autotoxic than 
6beneficial
A number of studies suggest that 
dysregulated apoptotic immune cell death may play 
a role in contributing to the immune dysfunction and 
MOF observed during sepsis. These include 
increased proinflammatory [TNF, interleukin 1β, 
interferon-γ (IFN- γ, interleukin 8, etc.] and anti-
inflammatory (interleukin 6, interleukin 10, etc.) 
cytokines, elevated glucocorticoid levels secondary 
to adrenal cortex stimulation, increased production 
of ROS associated with ischemia/reperfusion, and 
the presence of bacterial wall products in the 
systemic circulation, heat shock, oxygen free 
radicals, nitric oxide (NO), Fas ligand (FasL), and 
cytotoxic T lymphocytes, which express FasL on 
their surface as a method of killing a Fas receptor-
5expressing cell . 
Apoptosis in Sepsis
Key cells involved in the inflammatory 
process (neutrophils, macrophages, dendritic cells, 
and lymphocytes) are also cells targeted for 
apoptosis. Apoptosis of immune cells is normally 
not a pathologic process because inflammatory cells 
must be eliminated so that inflammation does not 
continue unabated. However, in sepsis or other 
overwhelming inflammatory processes (like trauma 
and severe burns) there is extensive cell death of 
lymphocytes and dendritic cells and delayed cell 
death of neutrophils. This leads to a blunted immune 
response coinciding with increased cellular 
4damage . 
Leu k o cy t e s  a r e  r e s p o n s ib l e  f o r  
opsonization and phagocytosis of infected cells and 
antigens at the site of inflammation. Neutrophils are 
one of the main mediators of tissue injury and they 
play an important role in the inflammatory 
response. Neutrophils are one of the first cells to 
migrate to the site of inflammation with an average 
half life of 6–12 hours when unstimulated. The 
primary role of the neutrophil is to serve as an innate 
defense against infection by eliminating pathogens. 
As they kill pathogens using ROIs and a mixture of 
lytic enzymes, they can potentially contribute to 
bystander cell/organ injury. Their release of 
proteolytic enzymes, toxic oxygen metabolites, and 
anti-microbial peptides is associated with extensive 
tissue damage. Under steady state conditions and in 
the absence of cytokines or other proinflammatory 
agents, aged neutrophils typically undergo 
spontaneous apoptosis. Apoptotic neutrophils are 
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Pro-apoptotic proteins of the Bcl-2 family 
initiate apoptosis by blocking the anti-apoptotic 
activity of Bcl-2 and Bcl-xL by binding to their 
mitochondrial binding sites or by triggering the 
activation of pro-apoptotic Bax/Bak. A third type of 
pro-apoptotic activity is through the cytoplasmic 
protein, Bid. This molecule is found in the 
cytoplasm in an inactive form. When cleaved by 
activated caspase-8 from the extrinsic pathway, Bid 
(once activated, referred to as t-Bid) causes a 
structural change to Bax making it similar to the 
structure of the anti-apoptotic molecule, Bcl-2, 
allowing Bax to translocate to the mitochondria. 
This is but one method of cross-talk that occurs 
4between the intrinsic and extrinsic pathways .
There are at least 3 current theories 
describing the exact mechanism by which the Bcl-2 
pro-apoptotic proteins lead to increased 
36
Figure 2: The mitochondrial or intrinsic pathway.
Activation of the pro-apoptotic proteins Bax and Bak occurs through conversion of Bid to tBid by caspase-8 or-
10 and through activation of PUMA, Noxa, or other BH3 initiator proteins when p53 is induced by DNA 
damage. Activated Bax and Bak oligomerize at the mitochondrial membrane and cause the release of several 
mitochondrial factors. Cytochrome c combines with Apaf-1 and procaspase-9 forming an apoptosome. Also 
released from the mitochondria are Smac/DIABLO, proteins that inactivate IAPs. Activated caspase-9 then is 
able to activate caspase-3 or -7 allowing apoptosis to proceed. Also released from the mitochondria are EndoG 
and AIF that stimulate apoptosis independent of caspases. Bcl-2 and Bcl-xL block the activation of Bax and 
Bak. Bcl-2, B-cell lymphoma-2; IAP, inhibitor of apoptosis protein; Apaf-1, apoptosis-activating factor-1; 
Smac, second mitochondrial-derived activator of caspases; DIABLO, director inhibitor of apoptosis-binding 
protein with LOw pI; BH3, Bclhomology- 3; tBid, truncated Bid; EndoG, endonuclease G; AIF, apoptosis-
inducing factor; Bax, Bcl-2-associated protein x; Bak, Bcl-2- associated protein k. Source: O'Brien, M.A., et 
al. Apoptosis: A review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease. Journal of 
Veterinary Emergency and Critical Care 18(6). 2008; 572–585.
mitochondrial permeability. The first theory 
describes the insertion of Bcl-2 proteins into the 
mitochondrial membrane and directly forming a 
channel. A second theory explains the Bcl-2 
proapoptotic proteins interacting with other 
mitochondrial membrane proteins, possibly 
voltage-dependent anion channel, to form large 
pores. The size of the voltage-dependent anion 
channel is too small for proteins to pass, so this 
model assumes that there is a conformation change 
with Bcl-2 binding. The third theory describes the 
Bcl-2 proteins modulating the mitochondrial 
proteins resulting in the formation of a permeability 
transition pore and loss of membrane potential, 
organelle swelling, and loss of cytochrome c from 
the pore. Once the permeability of the membrane 
has been compromised, cytochrome c is released 
and combines with a cytosolic molecule called 
Rizka Humardewayanti-Nugroho
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then phagocytosed by macrophages that prevent 
them from releasing their cytotoxic contents into the 
extracellular milieu, which would occur if the cells 
died by necrosis. This safe removal of apoptotic 
neutrophils helps to limit tissue damage during the 
resolution of inflammation. Thus, the normal, 
constitutive apoptotic death of neutrophils and their 
clearance is thought to be an important limit on their 
4-6.potential to cause damage . 
Leukocyte-endothelial interactions, which 
may also contribute to inflammation-mediated 
injury, involve two sets of adhesion molecules, 
selectins, and integrins. P-selectin is expressed on 
platelets; E- and P-selectins are expressed by 
endothelial cells, whereas L-selectin is expressed on 
leukocytes. Selectins mediate neutrophil rolling 
along activated endothelial surfaces as circulating 
neutrophils decelerate to engage endothelial 
receptors. The beta-2 intergrins (CD11/CD18 
complexes) mediate tight adhesion to endothelial 
membranes, allowing subsequent egress of 
neutrophils to extravascular sites of inflammation. 
Activated neutrophils stimulate transendothelial 
albumin transport through intracellular adhesion 
molecule-1 mediated, Scr-dependent caveolin 
7phosphorylation . 
Neut rophi l s  cont r ibu te  to  b lood  
coagulation in localized inflammation and in 
generalized sepsis. During systemic inflammation, 
homeostatic mechanisms are compromised in the 
microc i rcu la t ion  inc lud ing  endothe l ia l  
hyperactivity, fibrin deposition, microvascular 
occlusion, and cellular exudates that further impede 
adequate tissue oxygenation. Neutrophils 
participate in these rheologic changes through their 
augmented binding to blood vessel walls and 
through the formation of platelet-leukocyte 
aggregates. Neutrophil elastase, other proteases, 
glycases and inflammatory cytokines degrade 
endogenous anticoagulant activity, and impair 
fibrinolysis on endothelial surfaces favoring a 
7procoagulant state .
Neutrophil apoptosis in sepsis
Once a neutrophil is released into 
circulation, its apoptotic program has been 
4activated . Although neutrophils are committed to 
apoptosis, their death can be delayed in sites of 
inflammation by external factors including pro-
nflammatory cytokines, bacterial membrane 
components such as lipopolysaccharide (LPS; 
endotoxin), and pro-granulocyte differentiation 
factors such as granulocyte and monocyte colony 
stimulating factor (GM-CSF). A hallmark of sepsis 
is the loss of normal apoptosis of neutrophils. 
Studies have shown that sepsis can shorten as well 
as prolong the life span of the activated neutrophils 
(early or delayed apoptosis, respectively). Early 
apoptosis of neutrophils dampens respiratory burst 
activity and may lessen secondary tissue injury. 
Delayed apoptosis of neutrophils is associated with 
the persistence of inflammation and localised tissue 
injury, contributes to increased cellular damage, 
especially in the lung, liver, kidneys, and 
6,7gastrointestinal tract .This prolonged life produces 
neighboring cell damage and contributes to 
activation of pro-inflammatory cytokines. 
Normally, pro-inflammatory mediators (TNF-α, IL-
1β, IL-6, IL-8, and IFN-γ) released from 
macrophages and neutrophils have overlapping 
effects and function to limit damage, combat 
pathogenic organisms, eliminate foreign antigens, 
and promote repair. Anti-inflammatory cytokines 
(IL-4, IL-10, TGF-β, soluble receptors and receptor 
antagonists) are also quickly released to try to 
reduce and locally contain the inflammatory 
response. Many of these inflammatory components 
are the key factors responsible for the dysregulated 
4apoptosis of immune cells in sepsis .
Acute respiratory distress syndrome 
(ARDS) is marked by significant pulmonary 
accumulation of neutrophils, and is considered to be 
a direct effect of neutrophil-induced injury. Cells 
retrieved from the lungs of septic patients show 
reduced rates of neutrophil apoptosis with the 
degree of inhibition paralleling the severity of 
sepsis. Additional studies have shown that increased 
apoptosis (via Fas/FasL-dependent mechanism) of 
pulmonary epithelial cells will lead to permeability 
4changes characteristic of ARDS . The cytokines 
produced by activated neutrophils summon 
macrophages to the area of inflammation; cytokines 
are also produced by tissue macrophages in 
4response to foreign invasion . 
Macrophages are antigen presenting cells 
(APC) capable of engulfing foreign material, 
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infected cells, and apoptotic cells through 
4recognition of specific cell surface molecules . 
In as many as 30% of bacteremic patients 
who die from systemic inflammatory response 
syndrome or multiple organ dysfunction syndrome, 
no focus of infection is identified. Premature B cell 
and intestinal epithelial cell death through apoptosis 
in the intestines is one theory to explain intestinal 
bacterial translocation and loss of the first line of 
4intestinal defense .
Lymphocyte apoptosis in sepsis
Lymphocytes (B and T cells) are central to 
the adaptive immune response and rapidly expand 
in response to cytokines and antigen-specific 
5stimulation . Lymphocytes need 2 signals to 
stimulate differentiation and initiation of the 
immune response. The first signal is the 
presentation of antigen thus accounting for the 
specificity of the response. The second signal 
involves costimulatory molecules on APCs or APC 
secretion of cytokines. The costimulatory 
molecules interact with specific T cell sites 
producing a pro-apoptotic or anti-apoptotic state. 
Failure of the appropriate second signal after 
interaction with an APC results in anergy or 
apoptosis of the lymphocyte. Anergy is a state of 
unresponsiveness to antigen. This is also the 
4mechanism for self-tolerance .
The significance of lymphocytes to the 
septic animal's survival is documented by the 
markedly reduced capacity of recombination 
activating gene (RAG)_/_. (lymphocyte-deficient) 
mice to survive cecal ligation and perforation 
5(CLP) . Normally, apoptosis of lymphocytes is a 
process to delete auto reactive lymphocytes or to 
5contain/resolve immune cell activation . 
During normal health, the immediate fate of 
each lymphocyte is determined through continuous 
summation of a stream of proapoptotic and 
antiapoptotic signals that arrive from its external 
environment and from its internal cytoplasmic 
milieu. A shift toward initiation of apoptosis should 
therefore be expected during the early phase of 
sepsis, when bacteria or their by products stimulate 
macrophages to release proapoptotic substances 
such as TNF-, nitric oxide, and glucocorticoids. As 
the disease develops, accumulating products of 
lymphocyte apoptosis can act as antiinflammatory 
s t i m u l i ,  w h i c h  c o n t r i b u t e  t o  t h e  
immunosuppression commonly observed as sepsis 
progresses to septic shock, and which can lead to a 
6state of immune paralysis before death . 
Overwhelming infection should lead to 
massive clonal expansion of B and T lymphocytes 
but instead there is significant loss of these cell lines 
in sepsis. Lack of stimulation by APC cells 
experiencing apoptosis leads to poor B cell and T 
cell stimulation. These unstimulated T cells are 
4removed by apoptosis . 
It is proposed that in the critically ill 
patient/animal, dysregulated lymphocyte apoptosis 
in the thymus, spleen, and GALT may lead to 
immune suppression, leaving the patient vulnerable 
to subsequent infections or unable to fight existing 
sepsis, resulting in MOF. In this respect, it was 
initially proposed that an increase in lymphocyte 
apoptosis as well as the loss of functionally 
responsive cells might serve to decrease the ability 
of the septic host to regulate the development of an 
immune response to opportunistic pathogens, 
thereby impairing the development of adaptive and 
innate immune system cross-talk needed to clear the 
5infection .
Hotchkiss and co-workers have shown an 
increase in splenic lymphocyte apoptosis in septic 
mice, which is associated with an increase in 
mortality. Lymphocyte apoptosis may be associated 
with immune dysfunction as a result of decreased 
proliferation and interferon-γ (IFN-γ) release 
capability. IFN-γ is a potent macrophage activator 
and induces a Th1 response. As seen in apoptotic 
and necrotic splenocyte-adoptive transfer 
experiments, necrotic and apoptotic cells exercise 
their effects through variation of IFN-γ levels. 
Transfer of apoptotic splenocytes retro-orbitally in 
CLP mice decreased their survival, whereas 
adoptive transfer of necrotic splenocytes increased 
splenocyte IFN-γ and in doing so, improved 
survival. This survival benefit was blocked in IFN-
γ-deficient mice or in mice treated with an anti-IFN-
γ antibody. These results are interesting, as this 
adoptive transfer study illustrates the potential 
impact of apoptotic cells in vivo in sepsis and thus, 
points at another mechanism (besides loss/ death of 
functional immune cells; Fig. 3A) by which 
39
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immune suppression might be promulgated in the 
septic animal (Fig. 3B). Alternatively, the inability 
to clear these dying lymphocytes/cells  
appropriately (as a result of  dysfunction in these 
cell phagocytic capacities; often seen following 
sepsis and shock; refs.) may allow them to progress 
to a state of secondary necrosis, producing localized 
5bystander injury in the tissue (Fig. 3C) .
Numerous studies have demonstrated a 
massive apoptotic loss of lymphocytes during 
sepsis. A prospective investigation in adult patients 
compared spleens obtained either intraoperatively 
or within 6 hours after death from sepsis or trauma 
and found that those from sepsis patients showed a 
marked decrease in B cells and CD4 T cells (Figure 
4). The degree of splenic B-cell depletion 
corresponded with the duration of sepsis. Active 
caspase-9 was present in splenic lymphocytes with 
apoptotic features, suggesting a mitochondrial-
mediated pathway of cell death, although evidence 
indicates that apoptotic cell death in patients with 
sepsis can also proceed by the death receptor 
pathway. In most patients, loss of cells from the 
spleen corresponded with a premortem decrease in 
6,8circulating lymphocytes .
Fig 3. A depiction of several possible mechanisms of immune suppression.
A depiction of several possible mechanisms of immune suppression. (A) The simple hypothesis  (mechanism) that the 
immune dysfunction observed is a result of advertant/inadvertent apoptotic (Ao) loss of immune cell 
potential/capacity resultant from extrinsic and/or intrinsic Ao pathway activation. Here, no consideration is made for 
Ao cell clearence. (B) Alternatively, the effect that clearance of necrotic and/or apoptotic cell materials has on the 
developing macrophage phenotype (proinflammatory vs. anti-inflammatory/immune-suppressive) is considered 
when phagocytic function is normal. HSP, Heat shock protein(s); TLR, Toll-like receptor; CD1d/MICA, nonvariant 
MHC I-like antigen family; FcR, immunoglobulin constant region receptor(s); CR, complement receptor(s); ScavR, 
scavenger receptor(s), which bind; PS, phosphatidyl serine; TGF-β, transforming growth factor-β. (C) Finally, a 
scheme in which phagocytic function is compromised, so as to block apoptotic cell clearance, subsequently allowing 
apoptotic cells to move into secondary necrosis, which in turn, produces bystander tissue injury. TSP: 
Thrombospondin; M, macrophage(s). Source: Wesche, D.E., et al. Leukocyte apoptosis and its significance in sepsis 
and shock. Journal of Leukocyte Biology Volume 78. August 2005; 325-37.
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Although there is a consensus that apoptosis is increased in lymphoid cell populations during 
sepsis syndrome, the humoral or endocrine factors that stimulate this increased apoptosis are still not 
3fully known .
Fig 4. Apoptotic pathways activated by cytolytic T cells.
Apoptosis can occur via cell-surface-death-receptor- or mitochondrial-dependent pathways. Cytotoxic T lymphocytes 
(CTLs) express Fas ligand (FasL), which binds to the death receptor Fas on the target cell. Fas then recruits the Fas-
associated death domain (FADD) adapter protein to form the death-inducing signalling complex, causing the activation 
of caspase-8. Caspase-8, in turn, activates the downstream caspases, such as caspase-3, culminating in apoptosis. The 
death signal can also be initiated by the release of mitochondrial cytochrome c and activation of the apoptotic protease-
activating factor 1 (Apaf-1)/caspase-9 complex following internal cellular damage. The released cytochrome c binds to 
and activates intracellular receptor proteins, such as Apaf-1, which again results in activation of caspases and apoptosis. 
Many of these interactions found in pro-apoptotic signalling pathways are mediated by one of three related 
protein–protein interaction motifs: death domains (DDs), death effector domains (DEDs) and caspase-recruitment 
domains (CARDs). CTLs trigger a second pro-apoptotic pathway through the protease granzyme B, which, once 
released from CTLs, is translocated into the target cell by perforin. This allows granzyme B to have access to various 
cytoplasmic substrates and to cleave and activate downstream caspases. Source: Thome, M, et al. Apoptotic pathways 
ac t i va t ed  by  cy to ly t i c  T ce l l  ( 1  s c r een ) .  2001 .  ( c i t ed  march  2011 )  Ava i l ab l e  f rom;  
http://www.nature.com/nri/journal/v1/n1/fig_tab/nri1001-050a_F1.html 
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parenchymal cell apoptosis. This increased 
hepatocellular apoptosis was an important signal for 
the transmigration of primed neutrophils 
sequestered in sinusoids. TNF-α induced neutrophil 
sequestration in hepatic sinusoids during sepsis and 
endotoxemia, which was also associated with 
3hepatocyte necrosis .
Endothelial Cell Failure and Apoptosis in Other 
Cells
Endothelial cells reside at the critical 
interface between the blood and tissue. Intact 
endothelial cells exhibit anticoagulant properties 
through elaboration of anticoagulant molecules such 
as protein C. These cells also serve as a barrier 
between blood products and procoagulant 
molecules, such as heparin, residing in the 
extracellular matrix. Endothelial disruption comes 
about because of increased expression of adhesion 
molecules on the endothelial cells, resulting in 
attachment of white blood cells. It has also become 
increasingly clear that abundant cross talk exists 
between the coagulation system and the 
inflammation system in sepsis. Endothelial cells will 
undergo apoptosis in response to several mediators 
in vitro, including some infectious agents. However, 
endothelial cells are relatively resistant to the effects 
of endotoxin, and several investigators have failed to 
demonstrate convincing evidence of endothelial cell 
apoptosis during sepsis. Although it is strongly 
suspected that endothelial cells are dysfunctional in 
septic patients, clear-cut documentation during in 
2vivo settings has been difficult to obtain .
CONCLUSION
Apoptosis is a normal biologic process 
necessary to maintain cellular homeostasis. 
Apoptosis, or programmed cell death, is 
character ized by nuclear  degenera t ion,  
condensation, and nuclear DNA degradation; 
phagocytosis of cell residua. There are characteristic 
pathways that lead to this form of cell death 
continually influenced by local cellular events, 
growth factors, and neighboring stresses. This 
complicated system has numerous built-in avenues 
and failsafe mechanisms, including pro-apoptotic 
and anti-apoptotic factors. During sepsis, just 2 of 
the many diseases causing dysregulation of the 
apoptotic process, cells are either killed too quickly 
or survive too long. MODS or even MOF are often 
associated with an increased rate of apoptosis in 
lymphoid cells and, to a lesser extent, in organ 
parenchyma.
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Fig 5. A summary of the general changes in the levels of apoptosis (Ao) and/or activation-induced cell death 
(AICD) reported in experimental sepsis (filled arrows) or shock/trauma (open arrows) in mice and septic-
critically ill patients, as well as the mediators reported to affect the onset and frequency of apoptosis in various 
immune as well as nonimmune cell types. GALT, Gut-associated lymphoid tissue; PMN, polymorphonuclear 
neutrophil; PAF, platelet-activating factor. Source: Wesche, D.E., et al. Leukocyte apoptosis and its 
significance in sepsis and shock. Journal of Leukocyte Biology Volume 78. August 2005; 325-37.
Dendritic cell apoptosis in sepsis
Dendritic cells, another type of APC, are 
viewed as the sentinels of the immune system. The 
dendritic cell is a critical link between the innate and 
adaptive immunity. Dendritic cells not only migrate 
to lymphoid organs and stimulate T cells after 
maturation, but they also play an integral part in 
8lymphocyte apoptosis and immune suppression . 
Like macrophages, mature dendritic cells are able to 
activate lymphocytes through the presentation of 
antigen. 
Immature dendritic cells are capable of 
ingesting apoptotic cells but this will render them 
incapable of maturing and stimulating T cells. 
Macrophages and dendritic cells will secrete IL-10 
after engulfing apoptotic cells. IL-10, considered an 
anti-inflammatory cytokine selectively blocks the 
maturation of dendritic cells. This has been shown to 
suppress the phagocytic activity as well as pro-
inflammatory cytokine production of alveolar 
macrophages. IL-6 is also secreted by dendritic cells 
after ingesting apoptotic cells, leading to autocrine 
blockage of maturation. This lack of maturation 
leads to a tolerogenic state with no further 
4stimulation of the immune system . After ingesting 
apoptotic cells, dendritic cells can mature only when 
there are danger signals expressed by the apoptotic 
cell or when dendritic cells are engulfing an 
excessive number of apoptotic cells. This leads to 
secretion of pro-inflammatory cytokines IL-1β and 
TNF-α by these signaled dendritic cells. Inadequate 
clearance of surplus apoptotic cells results in these 
cells becoming necrotic and inducing a pro-
4inflammatory response . Studies have demonstrated 
apoptosis of intestinal and splenic B cells, CD4 T 
cells and dendritic cells in sepsis. Dendritic cells, 
particularly those that are CD8+ lymphoid-derived, 
appear to be lost in the spleens of septic patients and 
mice]. This loss of dendritic cells by apoptosis has 
been seen to occur after CD3+ CD4+ T cell 
activation. However, the significance and the nature 
of this apoptotic dendritic cell response in septic 
5animals and patients remain to be fully explored .
Apoptosis In Parenchymal Cells
Although there is general agreement that 
apoptosis is increased in lymphoid cells during 
sepsis, data supporting a significant parenchymal 
cell apoptosis in solid organs during sepsis are much 
less convincing. In a murine endotoxemia model, 
endogenously produced TNF- induced massive 
hepatocyte apoptosis and death; however, 
hepatocyte apoptosis required the simultaneous 
presence of transcriptional inhibition by either D-
galactosamine or actinomycin-D. Caspase-3 
activity was essential for TNF-α-induced hepatic 
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